These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17571214)

  • 1. Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade glioma.
    Mineo JF; Bordron A; Baroncini M; Maurage CA; Ramirez C; Siminski RM; Berthou C; Dam Hieu P
    J Neurooncol; 2007 Dec; 85(3):281-7. PubMed ID: 17571214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosphingolipid component profiles or human gliomas--correlation to survival time and histopathological malignancy grading.
    Becker R; Rohlfs J; Jennemann R; Wiegandt H; Mennel HD; Bauer BL
    Clin Neuropathol; 2000; 19(3):119-25. PubMed ID: 14606584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a case-control study.
    Dropcho EJ; Soong SJ
    Neurology; 1996 Sep; 47(3):684-90. PubMed ID: 8797465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.
    Amoureux MC; Coulibaly B; Chinot O; Loundou A; Metellus P; Rougon G; Figarella-Branger D
    BMC Cancer; 2010 Mar; 10():91. PubMed ID: 20219118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models.
    Chonan M; Saito R; Shoji T; Shibahara I; Kanamori M; Sonoda Y; Watanabe M; Kikuchi T; Ishii N; Tominaga T
    Neuro Oncol; 2015 Nov; 17(11):1453-62. PubMed ID: 26008605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
    Ogura R; Tsukamoto Y; Natsumeda M; Isogawa M; Aoki H; Kobayashi T; Yoshida S; Okamoto K; Takahashi H; Fujii Y; Kakita A
    Neuropathology; 2015 Aug; 35(4):324-35. PubMed ID: 25950388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.
    Fels C; Schäfer C; Hüppe B; Bahn H; Heidecke V; Kramm CM; Lautenschläger C; Rainov NG
    J Neurooncol; 2000 Jul; 48(3):207-16. PubMed ID: 11100818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
    Vachher M; Arora K; Burman A; Kumar B
    J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas.
    Mitsuka K; Kawataki T; Satoh E; Asahara T; Horikoshi T; Kinouchi H
    Neurosurgery; 2013 Jun; 72(6):1031-8; discussion 1038-9. PubMed ID: 23426156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of diagnostic neuronal markers and outcome in glioblastoma.
    Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.
    Lehman NL; O'Donnell JP; Whiteley LJ; Stapp RT; Lehman TD; Roszka KM; Schultz LR; Williams CJ; Mikkelsen T; Brown SL; Ecsedy JA; Poisson LM
    Cell Cycle; 2012 Feb; 11(3):489-502. PubMed ID: 22274399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
    Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
    J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between the expression of O6-methylguanine-DNA methyltransferase in glioma and the survival time of patients].
    Sun YH; Zhang YZ; Wang ZC; Sun MZ; Zhao DH
    Ai Zheng; 2004 Sep; 23(9):1052-5. PubMed ID: 15363200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLEKHG5 is a novel prognostic biomarker in glioma patients.
    Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
    Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
    Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
    Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
    Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.